Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Including known covariates can reduce power to detect genetic effects in case-control studies.
France Banned AB Science Drug Studies Because of Side Effects
Hereditary and inflammatory neuropathies: a review of reported associations, mimics and misdiagnoses.
Inhibition by riluzole of electrophysiological responses mediated by rat kainate and NMDA receptors expressed in Xenopus oocytes.
[2012: Update on diagnosis and treatment of multiple sclerosis].
Conditional DC depletion does not affect priming of encephalitogenic Th cells in EAE.
No MRI evidence of cortical lesions in neuromyelitis optica.
Endogeneous Remyelination: Findings in Human Studies.
"Bright spotty lesions" on spinal magnetic resonance imaging differentiate neuromyelitis optica from multiple sclerosis.
Inhibition of autoimmune encephalomyelitis by a tetracycline.
Fingolimod to treat severe multiple sclerosis after natalizumab-associated progressive multifocal leukoencephalopathy: a valid option?
Defining high, medium and low impact prognostic factors for developing multiple sclerosis.
UCSF Neuroimmunology Research Seminar
Uncovering Cryptic Glycan Markers in Multiple Sclerosis (MS) and Experimental Autoimmune Encephalomyelitis (EAE).
[Cognitive performance and quality of life in multiple sclerosis in Gipuzkoa].
Simvastatin: a review.
Parallel states of pathological Wnt signaling in neonatal brain injury and colon cancer.
Strategies for myelin regeneration: lessons learned from development.
Treatment of progressive multiple sclerosis with pulse cyclophosphamide/methylprednisolone: response to therapy is linked to the duration of progressive disease.
Quality of life in the care home: a qualitative study of the perspectives of residents with multiple sclerosis.
A unifying multiple sclerosis etiology linking virus infection, sunlight, and vitamin D, through viral interleukin-10.
Genetics of primary progressive multiple sclerosis.
Multiple Sclerosis: Changes in Microarchitecture of White Matter Tracts after Training with a Video Game Balance Board.
▼Dimethyl fumarate for relapsing-remitting multiple sclerosis.
Oral fingolimod (FTY720) for relapsing multiple sclerosis.
Pages
« first
‹ previous
…
189
190
191
192
193
194
195
196
197
…
next ›
last »